Literature DB >> 16359321

Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli.

Carlos Balsalobre1, Jose Manuel Silván, Stina Berglund, Yoshimitsu Mizunoe, Bernt Eric Uhlin, Sun Nyunt Wai.   

Abstract

The alpha-haemolysin is an important virulence factor commonly expressed by extraintestinal pathogenic Escherichia coli. The secretion of the alpha-haemolysin is mediated by the type I secretion system and the toxin reaches the extracellular space without the formation of periplasmic intermediates presumably in a soluble form. Surprisingly, we found that a fraction of this type I secreted protein is located within outer membrane vesicles (OMVs) that are released by the bacteria. The alpha-haemolysin appeared very tightly associated with the OMVs as judged by dissociation assays and proteinase susceptibility tests. The alpha-haemolysin in OMVs was cytotoxically active and caused lysis of red blood cells. The OMVs containing the alpha-haemolysin were distinct from the OMVs not containing alpha-haemolysin, showing a lower density. Furthermore, they differed in protein composition and one component of the type I secretion system, the TolC protein, was found in the lower density vesicles. Studies of natural isolates of E. coli demonstrated that the localization of alpha-haemolysin in OMVs is a common feature among haemolytic strains. We propose an alternative pathway for the transport of the type I secreted alpha-haemolysin from the bacteria to the host cells during bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16359321     DOI: 10.1111/j.1365-2958.2005.04938.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  65 in total

1.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

2.  Role of the lipopolysaccharide-CD14 complex for the activity of hemolysin from uropathogenic Escherichia coli.

Authors:  Lisa E Månsson; Peter Kjäll; Shahaireen Pellett; Gábor Nagy; Rodney A Welch; Fredrik Bäckhed; Teresa Frisan; Agneta Richter-Dahlfors
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

3.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

4.  Recent advances in the expression, evolution, and dynamics of prokaryotic genomes.

Authors:  Cecilia M Arraiano; Jaana Bamford; Harald Brüssow; Agamemnon J Carpousis; Vladimir Pelicic; Katharina Pflüger; Patrice Polard; Jörg Vogel
Journal:  J Bacteriol       Date:  2007-06-29       Impact factor: 3.490

5.  Proteomic characterization of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles.

Authors:  Frank Galka; Sun Nyunt Wai; Harald Kusch; Susanne Engelmann; Michael Hecker; Bernd Schmeck; Stefan Hippenstiel; Bernt Eric Uhlin; Michael Steinert
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

Review 6.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

7.  Engineered bacterial outer membrane vesicles with enhanced functionality.

Authors:  Jae-Young Kim; Anne M Doody; David J Chen; Gina H Cremona; Michael L Shuler; David Putnam; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-04-09       Impact factor: 5.469

8.  Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.

Authors:  Linxiao Chen; Jenny L Valentine; Chung-Jr Huang; Christine E Endicott; Tyler D Moeller; Jed A Rasmussen; Joshua R Fletcher; Joseph M Boll; Joseph A Rosenthal; Justyna Dobruchowska; Zhirui Wang; Christian Heiss; Parastoo Azadi; David Putnam; M Stephen Trent; Bradley D Jones; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

9.  Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.

Authors:  Taylor C Stevenson; Colette Cywes-Bentley; Tyler D Moeller; Kevin B Weyant; David Putnam; Yung-Fu Chang; Bradley D Jones; Gerald B Pier; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

Review 10.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.